Sight Sciences ex-officer plans sale of 13K shares
Sight Sciences, Inc. (SGHT) is the issuer for a planned sale of common stock reported under Rule 144 for the account of former officer Jeremy B. Hayden.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Sight Sciences, Inc. (SGHT) is the issuer for a planned sale of common stock reported under Rule 144 for the account of former officer Jeremy B. Hayden. A brokerage account at Fidelity Brokerage Services LLC filed notice to sell up to 13,253 shares of SGHT common stock, with an indicated value of $109,974.72. The securities relate to restricted stock vesting on 08/31/2026, received from the issuer as compensation. The filer notes that the sale includes an amount necessary to cover a tax obligation arising from settlement of a vested equity award.
In the prior three months, Jeremy Hayden reported several open-market sales of SGHT common stock, including 12,733 shares on 07/06/2026 for $70,132.10 and 48,000 shares on 08/14/2026 for $395,880.00, along with additional transactions on 08/11/2026, 08/12/2026, 08/13/2026, and 08/17/2026.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock vesting financial
equity award distribution financial
attorney-in-fact regulatory
tax obligation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for SGHT disclose about Jeremy Hayden's planned sale?
What types of SGHT securities are involved in this Form 144 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.